Chancellor Rachel Reeves Plans Specific Measures on Living Costs in Upcoming Financial Plan

Chancellor Rachel Reeves has revealed she is preparing "specific steps to deal with household expense pressures" in the upcoming Budget.

During an interview with media outlets, she noted that curbing inflation is a shared duty of both the government and the Bank of England.

The United Kingdom's price growth is expected to be the most elevated among the Group of Seven advanced economies this calendar year and next.

Potential Energy Cost Interventions

Reports indicate the government could intervene to bring down energy bills, for instance by cutting the present 5% rate of VAT applied on energy.

A further option is to reduce some of the government charges currently added to household expenses.

Budgetary Constraints and Expert Predictions

The administration will receive the latest report from the official forecaster, the OBR, on Monday, which will reveal how much scope there is for such actions.

The consensus from most economists is that the Chancellor will have to declare higher taxes or expenditure reductions in order to adhere to her voluntary borrowing rules.

Earlier on Thursday, estimates indicated there was a £22 billion deficit for the Treasury chief to resolve, which is at the lower end of forecasts.

"It is a collective task between the Bank of England and the administration to bear down further on some of the causes of inflation," the Chancellor informed the BBC in Washington, at the annual meetings of the IMF and global financial institution.

Revenue Commitments and International Issues

While much of the attention has been on probable tax increases, the Treasury chief said the most recent data from the OBR had not changed her commitment to manifesto promises not to increase rates on income tax, VAT or social security contributions.

She attributed an "uncertain global environment" with rising international and commercial tensions for the fiscal tax moves, likely to be targeted on those "wealthiest."

Global Economic Disputes

Commenting on worries about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security always come first."

Recent announcement by China to strengthen export controls on rare earths and other resources that are crucial for high-technology manufacturing led US President Donald Trump to suggest an extra 100% import tax on imports from China, increasing the possibility of an full-scale trade war between the two global powers.

The US Treasury Secretary labeled the Chinese decision "commercial pressure" and "a international production control attempt."

Questioned on accepting the US offer to participate in its dispute with China, the Chancellor said she was "deeply worried" by China's measures and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "harmful for the world economy and creates additional obstacles."

"I believe there are areas where we must confront Chinese policies, but there are also significant prospects to export to Chinese markets, including financial services and other sectors of the economy. We've got to maintain that balance appropriate."

The chancellor also confirmed she was working with international partners "on our own essential resources plan, so that we are more independent."

NHS Medicine Costs and Funding

The Chancellor also admitted that the cost the National Health Service pays for drugs could increase as a result of current discussions with the US government and its drugs companies, in exchange for reduced taxes and investment.

A number of the world's largest drug companies have said recently that they are either halting or abandoning investments in the UK, with some attributing the low prices they are obtaining.

Recently, the government science advisor said the price the NHS spends on medicines would must go up to halt businesses and drug research funding departing from the UK.

The Chancellor told the BBC: "It has been observed as a result of the pricing regime, that clinical trials, recent pharmaceuticals have not been offered in the UK in the extent that they are in other EU nations."

"The objective is to ensure that individuals getting treatment from the National Health Service are can obtain the finest critical drugs in the world. And so we are reviewing these issues, and... seeking to obtain more funding into the UK."